The multifactorial nature of Alzheimer's disease for developing potential therapeutics.
about
Ammonia as a Potential Neurotoxic Factor in Alzheimer's DiseaseOne for All? Hitting Multiple Alzheimer's Disease Targets with One DrugRole of berberine in Alzheimer's diseaseFenugreek Seed Powder Nullified Aluminium Chloride Induced Memory Loss, Biochemical Changes, Aβ Burden and Apoptosis via Regulating Akt/GSK3β Signaling PathwayMultifunctional Effects of Mangosteen Pericarp on Cognition in C57BL/6J and Triple Transgenic Alzheimer's Mice.Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer's disease.Multitarget-directed tricyclic pyridazinones as G protein-coupled receptor ligands and cholinesterase inhibitors.L-3-n-butylphthalide Rescues Hippocampal Synaptic Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model of Alzheimer's Disease.The ATP-Binding Cassette Transporter-2 (ABCA2) Overexpression Modulates Sphingosine Levels and Transcription of the Amyloid Precursor Protein (APP) Gene.Conjugates of γ-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDA receptors for Alzheimer DiseaseNovel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer's Agents: Design, Synthesis and Biological Evaluation.Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer's Disease.Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.Mechanistic Insight of Bivalent Compound 21MO as Potential Neuroprotectant for Alzheimer's DiseasePreclinical Evaluation of miR-15/107 Family Members as Multifactorial Drug Targets for Alzheimer's DiseaseThe Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.Etiology and pathogenesis of late-onset Alzheimer's disease.Preliminary Data on the Interaction between Some Biometals and Oxidative Stress Status in Mild Cognitive Impairment and Alzheimer's Disease Patients.Natural Xanthones from Garcinia mangostana with Multifunctional Activities for the Therapy of Alzheimer's Disease.Searching for Multi-Targeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif.Novel 8-Hydroxyquinoline Derivatives as Multitarget Compounds for the Treatment of Alzheimer's Disease.Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy.Bivalent ligands incorporating curcumin and diosgenin as multifunctional compounds against Alzheimer's disease.Morphogens and blood-brain barrier function in health and disease.Bivalent Compound 17MN Exerts Neuroprotection through Interaction at Multiple Sites in a Cellular Model of Alzheimer's DiseaseNew neurogenic lipoic-based hybrids as innovative Alzheimer's drugs with σ-1 agonism and β-secretase inhibition.Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer's disease management.Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends.Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment.Editorial: Computational and Experimental Approaches in Multi-target Pharmacology.New semicarbazones as gorge-spanning ligands of acetylcholinesterase and potential new drugs against Alzheimer's disease: Synthesis, molecular modeling, NMR, and biological evaluation.Pro-neurogenic, Memory-Enhancing and Anti-stress Effects of DF302, a Novel Fluorine Gamma-Carboline Derivative with Multi-target Mechanism of Action.Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer's Disease.Design, synthesis, and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.Synthesis and evaluation of paeonol derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.Pharmacotherapy of Alzheimer's disease: current and future trends.Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta.Design and characterization of bivalent compounds as potential neuroprotectants for Alzheimer's disease: Impact of the spacer on biological activity.
P2860
Q26739873-1E8A0B0D-E80D-495D-B937-4F61F14DE38BQ26747572-ADF730EC-ED26-4418-A940-D33617B576DCQ28067321-E7898ACD-C14E-4A0C-9E21-9909FBCB8CF5Q28554441-A949CDB2-27D1-4197-88E7-3FAA1E0D9D8EQ34710160-1D61309B-EDEC-4B0A-9CFB-48C018B3B529Q35617556-7D8420B7-E8FA-4D12-8AD1-F01F056C603CQ35618019-D10DB41B-DEA2-466A-8BA5-F0B65BCC9387Q36083357-ABAAFD33-8F9A-4401-86B0-97828767F291Q36242712-F04A4E96-D5A2-41A8-9A39-35500A3ED13FQ36273566-FD1539BC-FD1E-487F-BD61-E77BFA4F8684Q36407216-BCDF3F19-2EAA-4FE1-8758-6C3AABADE69EQ36771721-268942F9-3EE5-439B-A30D-41F341721B31Q36794953-39EAE526-6B6C-4450-9808-762D545FBAE8Q36797971-DDCED79B-7C44-4827-8454-0E3BF984D4F1Q36939748-42A65A87-3F58-438C-8287-5730D09B1949Q38177234-2B544EE7-51D6-47CD-B5A8-26677AD00716Q38178837-6E03019F-044D-4821-B86C-7A8E955D1593Q38622838-438E1C3A-EF67-464F-AEBC-1AD968B78926Q38781331-5C8DD396-356E-46C9-9D75-049DBBD2EBA3Q38784489-A611CA33-40D2-4E91-97EA-3CC25D0CFB08Q38793949-911F85A7-D49F-4287-85F7-D3C1BDBFB3DBQ38806779-9915155B-9AFC-4B6D-827C-97761BEA3EA6Q38822745-EC5E6425-2ED1-4471-82D2-EC2A4C896B8BQ38824367-CE723952-4CDE-40C9-9081-30225D974B92Q38832920-DA35F11A-6540-40E2-9EAE-355ABE88B4A4Q38842928-AD6CC674-8953-4930-BE5A-E85DC9EC2865Q38899961-DCED7A82-FBA5-4E58-BF50-C003F2A2929CQ39022532-0C3A0BC7-93E2-4F3F-A760-C6C8ED1E4FFAQ40777740-F746CC64-3C71-4AC6-A6C7-FB2D25AA4F02Q42293352-F5E71478-ACCA-4C72-94BC-A598AA7DFBE8Q42333457-1E6FB13C-6D1D-4A6C-B95F-8444969FD27EQ47290054-CB211A46-85E7-45BC-8827-2E3F7850AFE3Q47633396-1ECC97FF-7668-419D-B7DB-79D52AD9E358Q47899443-E81CD349-2135-47B1-A573-CF237C1F12C2Q48193681-75B9FD00-7837-4532-A410-D079E84E320DQ48373986-ADF10674-7593-4376-AB7B-D0A83DA3F73DQ48678220-4FFBD4D5-847F-402B-AC4F-862A49FC25E9Q50857626-E4152BFF-469A-4AE8-915D-5F44700A6987Q52687867-F9D2007B-E0CF-4F86-A5E0-166F87AC0374
P2860
The multifactorial nature of Alzheimer's disease for developing potential therapeutics.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The multifactorial nature of Alzheimer's disease for developing potential therapeutics.
@en
type
label
The multifactorial nature of Alzheimer's disease for developing potential therapeutics.
@en
prefLabel
The multifactorial nature of Alzheimer's disease for developing potential therapeutics.
@en
P2093
P1476
The multifactorial nature of Alzheimer's disease for developing potential therapeutics
@en
P2093
Ana Paula Francisco
Eduarda Mendes
J Marco-Contelles
M Jesus Perry
P304
P356
10.2174/15680266113139990135
P577
2013-01-01T00:00:00Z